News for 'India Pharma Inc'

Korean drug majors eye local pacts

Korean drug majors eye local pacts

Rediff.com7 Dec 2005

How US companies are helping India fight coronavirus

How US companies are helping India fight coronavirus

Rediff.com16 Apr 2020

A large number of American companies like Google, Uber and IBM are offering their resources to help India successfully fight the battle against the deadly coronavirus pandemic.

'The more prudent thing would be to buy on dips'

'The more prudent thing would be to buy on dips'

Rediff.com14 Apr 2022

'The recent correction in indices has made the markets cheaper to invest for the long term.'

How India's top business houses fared in 2015-16

How India's top business houses fared in 2015-16

Rediff.com15 Apr 2016

Consumer businesses come to the rescue of large conglomerates in the midst of a meltdown in commodities.

Deal Street dazzles thanks to Reliance's equity divestment

Deal Street dazzles thanks to Reliance's equity divestment

Rediff.com30 Dec 2020

Record equity divestment by the Reliance Group in its telecom and retail businesses garnering around $23 billion revved up the deal street in 2020, which otherwise would have gone down as one of the dullest on record, and dealmakers are seeing sunnier days in 2021 given the large scope for consolidation in a slew of sectors ravaged by the pandemic. With Jio Platforms alone garnering over $16 billion (Rs 1,18,318 crore) by selling 25.24 per cent stake and Reliance Retail notching up $6.4 billion (Rs 47,265 crore) by divesting around 9 per cent shareholding, the deal street signed off with $85 billion in the deal kitty across 1,270 transactions. This is higher by about 10 per cent over 2019. What is significant is that over a third of the total deal value came from Reliance transactions, say investment bankers.

Rs 1-trillion m-cap club now has 42 members with 13 new entrants

Rs 1-trillion m-cap club now has 42 members with 13 new entrants

Rediff.com17 May 2021

Thirteen companies have joined the Rs 1-trillion-plus market capitalisation club this year, so far. This even as the benchmark Sensex has gained less than 3 per cent on a year-to-date basis, underscoring the bullish undercurrent in the broader market. The trend shows a harsh second wave of Covid-19, subsequent lockdowns, and hit to the economic activity has made little dent into India Inc or shareholders' wealth. At the start of the year, there were 29 companies with a market value of more than Rs 1 trillion.

Why Should Govt Be In Fintech?

Why Should Govt Be In Fintech?

Rediff.com15 Dec 2021

The temptation to get into businesses that are hot is perhaps too great for any politician, no matter what his public slogans are. Nehru plunged into hot sectors of his time -- engineering and iron and steel. Modi has plunged into digital payments -- the hot sector of his time, notes Debashis Basu.

'In the short term, the markets may remain weak due to rising Covid cases'

'In the short term, the markets may remain weak due to rising Covid cases'

Rediff.com7 May 2021

'In the short term, we may see some disruptions due to Covid, but in the medium-to-long term, we should keep an eye on US inflation and 10-year bond yields.'

'Equity markets should remain in favour in 2022'

'Equity markets should remain in favour in 2022'

Rediff.com14 Jan 2022

'The markets have corrected almost 8-9 per cent from their highs, so one can accumulate quality stocks at reasonable prices.'

Twitter deliberately chose path of non-compliance: Prasad

Twitter deliberately chose path of non-compliance: Prasad

Rediff.com16 Jun 2021

Lashing out at the micro-blogging platform over non-compliance, Prasad said that it is "astounding" that Twitter that portrays itself as the flag bearer of free speech, chooses the path of deliberate defiance when it comes to the intermediary guidelines.

'This cycle will only break if a few high-profile issues 'bomb''

'This cycle will only break if a few high-profile issues 'bomb''

Rediff.com14 Sep 2021

'It really doesn't matter that investors getting allotments sell their IPO stock holdings on listing day because a new set of investors are entering.' 'This explains the continued rise in stock prices even after the first day of listing.'

Jan, Feb saw upswing in hiring activity: Naukri

Jan, Feb saw upswing in hiring activity: Naukri

Rediff.com13 Mar 2013

Was led by sectors like software services, BPO and pharma.

Russian vaccine has efficacy of over 95%: RFID CEO

Russian vaccine has efficacy of over 95%: RFID CEO

Rediff.com24 Nov 2020

In a virtual conference from Moscow, Dmitriev said Sputnik V is not only 'one of the most effective' but also among the 'affordable' vaccines in the world.

Ranbaxy's top executives in the US resign

Ranbaxy's top executives in the US resign

Rediff.com14 Oct 2014

US country head, key departmental heads leave; more likely to follow.

Govt clears 15 FDI proposals

Govt clears 15 FDI proposals

Rediff.com27 Sep 2013

The 15 proposals were cleared following recommendations by Foreign Investment Promotion Board.

Ranbaxy's US arm to face patent infringement suit

Ranbaxy's US arm to face patent infringement suit

Rediff.com11 May 2010

US-based Purdue Pharma has filed a patent infringement suit against India's largest drug company, Ranbaxy, after the latter's wholly-owned US subsidiary, Ranbaxy Pharmaceuticals Inc, applied for marketing approval of a low-cost version of Purdue's pain relieving medicine, Oxycodone.

FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

Rediff.com13 Jan 2014

The Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33 per cent stake or 2.06 crore equity shares in GlaxoSmithKline Pharmaceuticals Ltd through an open offer.

India scraps import duties on AIDS drugs to battle shortage

India scraps import duties on AIDS drugs to battle shortage

Rediff.com11 Jun 2015

Drugs under exemption make up roughly 95 per cent of the antiretrovirals used by India's AIDS patients

Govt approves 2 new vaccines, Covid drug for emergency use

Govt approves 2 new vaccines, Covid drug for emergency use

Rediff.com28 Dec 2021

The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the CDSCO recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.

'Invest in mid-caps very selectively'

'Invest in mid-caps very selectively'

Rediff.com25 Sep 2018

Even as rising crude oil prices, trade war fears and a sliding rupee cast a shadow on market sentiment, Nischal Maheshwari, chief executive officer for institutional equities and advisory at Centrum Broking, tells Puneet Wadhwa that in the next one year, the outcome of the 2019 general election is a bigger challenge for the market.

'It will remain a stock pickers' market'

'It will remain a stock pickers' market'

Rediff.com2 Aug 2021

'At this moment, investors should look for relative value within sectors and clear visibility (third-wave-or-not) on earnings delivery.'

10 things that will make 2021 different!

10 things that will make 2021 different!

Rediff.com10 Jan 2021

From 5G to Tesla to Covid vaccine, 10 things will shape India's future.

'Real money in the market is made by remaining invested for long'

'Real money in the market is made by remaining invested for long'

Rediff.com9 Aug 2021

'Waiting for a market correction and optimising entry time in the markets will be akin to missing the woods for the trees.'

Pfizer may merge Duchem with itself

Pfizer may merge Duchem with itself

Rediff.com24 Apr 2006

Sensex gets a boost from lower crude prices, firm rupee and Kotak Bank

Sensex gets a boost from lower crude prices, firm rupee and Kotak Bank

Rediff.com7 Dec 2018

Kotak Mahindra Bank was the biggest gainer on both the indices, ending nearly 9 per cent higher following reports that Warren Buffett's Berkshire Hathaway Inc was planning to pick up stake in the private sector lender.

Twitter deliberately chose path of non-compliance: Prasad

Twitter deliberately chose path of non-compliance: Prasad

Rediff.com16 Jun 2021

IT minister Ravi Shankar Prasad on Wednesday slammed Twitter for deliberate defiance and failure to comply with the country's new IT rules, which has led to the United States giant losing its intermediary status in India and becoming liable for users posting any unlawful content.

Nicholas Piramal to buy Pfizer's UK facility

Nicholas Piramal to buy Pfizer's UK facility

Rediff.com15 Jun 2006

Nicholas Piramal India Ltd said on Thursday its UK subsidiary has entered into an agreement to acquire the manufacturing facility of global pharma company Pfizer Inc at Morpeth, UK, on an asset purchase basis.

IT sector beats financial firms in salary payouts

IT sector beats financial firms in salary payouts

Rediff.com8 Jun 2014

Going by the current pace, IT firms are likely to exceed the manufacturing sector in salary payouts over the next five years.

India to remain in lockdown till May 3, announces PM Modi

India to remain in lockdown till May 3, announces PM Modi

Rediff.com14 Apr 2020

In a nearly 25-minute televised address to the nation, Modi said implementation of the lockdown will be strictly ensured in its second phase and detailed guidelines will be brought out on Wednesday to ensure that outbreak does not spread to new areas.

Momentum of economic reforms will continue: Sitharaman

Momentum of economic reforms will continue: Sitharaman

Rediff.com23 Nov 2020

Finance Minister Nirmala Sitharaman on Monday assured the industry that momentum of economic reforms will continue to make India a hotspot of global investment. India has turned the crisis created by COVID-19 pandemic into an opportunity to push the economic reforms, which remained pending for decades, she said while addressing the National MNC's Conference 2020 organised by industry chamber CII.

India's 6 super achievers in Asia's powerful women list

India's 6 super achievers in Asia's powerful women list

Rediff.com27 Feb 2015

Six Indian women have made it to Asia's most powerful women list released by Forbes.

PSUs became the biggest laggards on Indian bourses

PSUs became the biggest laggards on Indian bourses

Rediff.com4 Feb 2021

Market cap of government companies has remained unchanged in the past 8 years.

Dhirubhai Ambani, Dilip Shanghvi chosen for Padma awards

Dhirubhai Ambani, Dilip Shanghvi chosen for Padma awards

Rediff.com25 Jan 2016

Dhirubhai Ambani lived in a one-room chawl in Mumbai with his wife and children and went on to establish the Reliance Group.

Sensex zooms 390 points to snap 3-day losing streak

Sensex zooms 390 points to snap 3-day losing streak

Rediff.com9 Oct 2014

Markets extended gains led by financials and capital goods shares coupled with a rebound in IT shares.

Profit boom amid sales gloom

Profit boom amid sales gloom

Rediff.com8 Jul 2013

Brokerages expect Nifty50 firms to post 11.8% growth in net profit in Q1 but sales may decline

'The markets can always disappoint you'

'The markets can always disappoint you'

Rediff.com29 Jul 2020

'People are doing a lot of trading.' 'Short-term euphoria can be seen.' 'Retail participation is best through MFs and PMS.'

Nifty tops 8,500 to end at highest close since August 2015

Nifty tops 8,500 to end at highest close since August 2015

Rediff.com12 Jul 2016

ICICI Bank was the top Sensex gainer after S&P Global Ratings affirmed its 'BBB-' long-term issue ratings on the senior unsecured bonds.

Has India achieved economic recovery? Not yet!

Has India achieved economic recovery? Not yet!

Rediff.com18 Nov 2014

Profits grow, but not because of recovering demand.

Health ministry okays HCQ for early course of COVID-19

Health ministry okays HCQ for early course of COVID-19

Rediff.com13 Jun 2020

The health ministry on Saturday recommended the use of antiviral drug remdesivir in moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the anti-malarial drug should be used in the early course of the disease and not on critically ill patients.

Stronger rupee a risk to future corporate earnings

Stronger rupee a risk to future corporate earnings

Rediff.com7 Apr 2014

Corporate India's earnings in the past two quarters were largely driven by the rupee's sharp fall versus the dollar in the second quarter of this financial year.